KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma

Figure 1

KDELR3 expression levels in human cancers. (a) Using data from TCGA database, GEPIA was able to assess the levels of KDELR3 expression in a variety of tumor types. (b) RT-PCR was utilized in order to investigate whether KDELR3 was expressed in MUM-2C, OCM-1A, MUM-2B, C918, and D78.

(a)

(b)